WallStreetZenWallStreetZen

NYSE: ENOV
Enovis Corp Stock

Overview
ForecastEarningsRevenueDividendOwnership
$44.75-0.60 (-1.32%)
Updated Jan 14, 2025
ENOV Price
$44.75
Fair Value Price
N/A
Market Cap
$2.50B
52 Week Low
$38.27
52 Week High
$65.03
P/E
-20.53x
P/B
0.75x
P/S
1.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.00B
Earnings
-$119.19M
Gross Margin
56.8%
Operating Margin
-4.38%
Profit Margin
-6%
Debt to Equity
0.67
Operating Cash Flow
$94M
Beta
1.41
Next Earnings
Feb 20, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ENOV Overview

Enovis Corporation is a medical technology company focused on orthopedics. It manufactures medical devices for patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, or sports-related injuries. Formerly known as Colfax Corporation, Enovis was founded in 1995 and is headquartered in Wilmington, DE.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ENOV's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Value
B
Growth
D
Momentum
B
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Specialty Industrial Machinery

Industry Rating
B
ENOV
Ranked#36 of 76

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Power Solutions International (PSIX)
$36.19A
Luxfer Holdings (LXFR)
$12.80A
Mueller Water Products (MWA)
$22.41A
View Top Specialty Industrial Machinery Stocks

Be the first to know about important ENOV news, forecast changes, insider trades & much more!

ENOV News

Overview

Due Diligence Score

–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ENOV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ENOV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ENOV is good value based on its book value relative to its share price (0.75x), compared to the US Specialty Industrial Machinery industry average (5.41x)
P/B vs Industry Valuation
ENOV is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ENOV due diligence checks available for Premium users.

Valuation

ENOV price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-20.53x
Industry
27.94x
Market
30.21x

ENOV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.75x
Industry
5.41x
ENOV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ENOV's financial health

Profit margin

Revenue
$505.2M
Net Income
-$31.5M
Profit Margin
-6.2%
ENOV's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ENOV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.6B
Liabilities
$2.2B
Debt to equity
0.67
ENOV's short-term assets ($1.20B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENOV's long-term liabilities ($1.69B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENOV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ENOV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$53.6M
Investing
-$58.4M
Financing
-$148.0k
ENOV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ENOV vs Specialty Industrial Machinery Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ENOVC$2.50B-1.32%-20.53x0.75x
ATS–$2.57B-1.16%27.68x2.10x
B–$2.41B+0.06%-61.40x1.85x
SYMC$2.67B+2.70%-179.50x13.55x
EPACB$2.31B+1.85%25.72x5.80x
View Top Specialty Industrial Machinery Stocks

Enovis Stock FAQ

What is Enovis's quote symbol?

(NYSE: ENOV) Enovis trades on the NYSE under the ticker symbol ENOV. Enovis stock quotes can also be displayed as NYSE: ENOV.

If you're new to stock investing, here's how to buy Enovis stock.

What is the 52 week high and low for Enovis (NYSE: ENOV)?

(NYSE: ENOV) Enovis's 52-week high was $65.03, and its 52-week low was $38.27. It is currently -31.19% from its 52-week high and 16.93% from its 52-week low.

How much is Enovis stock worth today?

(NYSE: ENOV) Enovis currently has 55,875,456 outstanding shares. With Enovis stock trading at $44.75 per share, the total value of Enovis stock (market capitalization) is $2.50B.

Enovis stock was originally listed at a price of $63.00 in May 8, 2008. If you had invested in Enovis stock at $63.00, your return over the last 16 years would have been -28.97%, for an annualized return of -2.12% (not including any dividends or dividend reinvestments).

How much is Enovis's stock price per share?

(NYSE: ENOV) Enovis stock price per share is $44.75 today (as of Jan 14, 2025).

What is Enovis's Market Cap?

(NYSE: ENOV) Enovis's market cap is $2.50B, as of Jan 16, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Enovis's market cap is calculated by multiplying ENOV's current stock price of $44.75 by ENOV's total outstanding shares of 55,875,456.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.